AGY.L - Allergy Therapeutics plc

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
72,768
72,768
84,331
78,204
73,717
Cost of revenue
23,262
23,262
22,106
20,201
18,379
Gross profit
49,506
49,506
62,225
58,003
55,338
Operating expenses
Research development
15,659
15,659
12,887
5,848
6,950
Selling general and administrative
46,832
46,832
45,874
44,480
44,590
Total operating expenses
61,751
61,751
58,194
49,694
50,947
Operating income or loss
-12,245
-12,245
4,031
8,309
4,391
Interest expense
669
669
491
504
201
Income before tax
-12,657
-12,657
3,657
8,071
4,293
Income tax expense
1,119
1,119
771
1,013
826
Income from continuing operations
-13,776
-13,776
2,886
7,058
3,467
Net income
-13,776
-13,776
2,886
7,058
3,467
Net income available to common shareholders
-13,776
-13,776
2,886
7,058
3,467
Basic EPS
-
-
0.00
0.01
0.01
Diluted EPS
-
-
0.00
0.01
0.01
Basic average shares
-
-
639,190
636,169
632,835
Diluted average shares
-
-
676,658
673,492
669,703
EBITDA
-
-7,822
8,280
12,489
6,584